Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jason Silberman, M.D.

Concepts (18)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystadenocarcinoma, Papillary12023590.910 Why?
Cystadenocarcinoma, Serous120234500.680 Why?
Peritoneal Neoplasms120236650.590 Why?
Ovarian Neoplasms1202348380.280 Why?
Chemotherapy, Adjuvant1202334790.120 Why?
Neoadjuvant Therapy1202327280.100 Why?
Neoplasm Staging12023110310.080 Why?
Telemedicine1202128720.060 Why?
Lactation120214120.040 Why?
United States12023698720.030 Why?
Retrospective Studies12023774490.030 Why?
Prenatal Care1202110920.030 Why?
Pandemics2202183880.020 Why?
Female320233801940.020 Why?
Pregnancy22021291440.020 Why?
Vaccination1202132780.020 Why?
Humans320237443430.010 Why?
Infant, Newborn12021256250.010 Why?
Silberman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (18)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.